Phase II Pilot Trial of an Indoleamine 2, 3,diosygenase -1 ( IDO1) Inhibitor (INCBO24360) Plus a Multipeptide Melanoma Vaccine ( MELTAC 12.1 ) in Patients with Advanced Melanoma
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Fred Hutchinson Cancer Research Center
Start Date
September 1, 2015
End Date
August 31, 2017
Administered By
Medicine, Medical Oncology
Awarded By
Fred Hutchinson Cancer Research Center
Start Date
September 1, 2015
End Date
August 31, 2017